| The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation R Kedmi, N Ben-Arie, D Peer Biomaterials 31 (26), 6867-6875, 2010 | 522 | 2010 |
| CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy D Rosenblum, A Gutkin, R Kedmi, S Ramishetti, N Veiga, AM Jacobi, ... Science advances 6 (47), eabc9450, 2020 | 401 | 2020 |
| A modular platform for targeted RNAi therapeutics R Kedmi, N Veiga, S Ramishetti, M Goldsmith, D Rosenblum, N Dammes, ... Nature nanotechnology 13 (3), 214-219, 2018 | 271 | 2018 |
| Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes N Veiga, M Goldsmith, Y Granot, D Rosenblum, N Dammes, R Kedmi, ... Nature communications 9 (1), 4493, 2018 | 270 | 2018 |
| Systemic gene silencing in primary T lymphocytes using targeted lipid nanoparticles S Ramishetti, R Kedmi, M Goldsmith, F Leonard, AG Sprague, B Godin, ... ACS nano 9 (7), 6706-6716, 2015 | 184 | 2015 |
| A RORγt+ cell instructs gut microbiota-specific Treg cell differentiation R Kedmi, TA Najar, KR Mesa, A Grayson, L Kroehling, Y Hao, S Hao, ... Nature 610 (7933), 737-743, 2022 | 143 | 2022 |
| Redundant cytokine requirement for intestinal microbiota-induced Th17 cell differentiation in draining lymph nodes T Sano, T Kageyama, V Fang, R Kedmi, CS Martinez, J Talbot, A Chen, ... Cell reports 36 (8), 2021 | 32 | 2021 |
| SNP detection in mRNA in living cells using allele specific FRET probes L Dahan, L Huang, R Kedmi, MA Behlke, D Peer PLoS One 8 (9), e72389, 2013 | 24 | 2013 |
| Integrin-targeted nanoparticles for siRNA delivery N Ben-Arie, R Kedmi, D Peer Integrin and Cell Adhesion Molecules: Methods and Protocols, 497-507, 2012 | 13 | 2012 |
| TAF 4b and TAF 4 differentially regulate mouse embryonic stem cells maintenance and proliferation A Bahat, R Kedmi, K Gazit, I Richardo‐Lax, E Ainbinder, R Dikstein Genes to Cells 18 (3), 225-237, 2013 | 12 | 2013 |
| RNAi nanoparticles in the service of personalized medicine R Kedmi, D Peer Nanomedicine 4 (8), 853-855, 2009 | 10 | 2009 |
| Zooming in on selectins in cancer R Kedmi, D Peer Science translational medicine 8 (345), 345fs11-345fs11, 2016 | 6 | 2016 |
| Microbiota-instructed regulatory T cell differentiation is mediated by a distinct RORγt+ antigen presenting cell subset R Kedmi, T Najar, KR Mesa, A Grayson, L Kroehling, Y Hao, S Hao, ... bioRxiv, 2021.11. 19.469318, 2021 | 5* | 2021 |
| Immunoparticles and methods of generating and using same R Kedmi, D Peer US Patent 10,543,278, 2020 | 3 | 2020 |
| Modular platform for targeted therapeutics R Kedmi, N Veiga, I Benhar, D Peer US Patent 11,708,421, 2023 | 2 | 2023 |
| Coordinated network of T cells and antigen presenting cells regulate tolerance to food A Rudnitsky, H Oh, J Talmor, R Kedmi bioRxiv, 2024.07. 11.603064, 2024 | 1 | 2024 |
| Antigen-presenting cells as specialized drivers of intestinal T cell functions R Kedmi, DR Littman Immunity 57 (10), 2269-2279, 2024 | | 2024 |
| Modular platform for targeted therapeutics R Kedmi, N Veiga, I Benhar, D Peer US Patent App. 18/206,645, 2023 | | 2023 |
| Immunoparticles and methods of generating and using same R Kedmi, D Peer US Patent 11,338,042, 2022 | | 2022 |
| Abstract B167: Antigen-presenting cells as coordinators of T-cell responses to gut microbiota R Kedmi, K Mesa, D Littman Cancer Immunology Research 7 (2_Supplement), B167-B167, 2019 | | 2019 |